Weak inter-or intramolecular interactions, especially when combined and integrated into appropriate molecular "architecture", can lead to the formation of supramolecular structures with specific functionality."] Here we report a system that, owing to such interactions in the solid, shows strong luminescence from a metal-to-ligand charge-transfer (MLCT) excited state.Compounds 1-3, which belong to the class of homodinuclear complexes containing the bridging ligand 2,T-bipyriml a
Eine π‐Wechselwirkung Phenyl…︁bpym…︁Phenyl sowie durch Lösungsmittelmoleküle fixierte BF ⊖4‐Gegenionen sind Ursache für die starke Lumineszenz von 1 im Festkörper. Dies folgt daraus, daß sowohl mit einer Reihe anderer Arylphosphanliganden als auch mit PF ⊖6‐ und ClO ⊖4‐Gegenionen sowie in Lösung keine oder nur eine sehr schwache Lumineszenz aus dem Metall‐Ligand‐Charge‐Transfer‐angeregten Zustand beobachtet wird.
structure structure (organic substances) K 9000 13 -052 Ultraviolet Stabilizers of the 2-(Hydroxyphenyl)benzotriazole Class. Influence of Substituents on Structure and Spectra -(X-ray analyses, absorption, IR and fluorescence spectra of 8 title compounds such as (I) substituted in the phenol substituent and 4 title compounds such as (II) substituted in both phenyl rings). -(RIEKER, J.; LEMMERT-SCHMITT, E.; GOELLER, G.; ROESSLER, M.; STUEBER, G. J.; SCHETTLER, H.; KRAMER, H. E. A.; STEZOWSKI, J. J.; HOIER, H.; HENKEL, S.; SCHMIDT, A.; PORT, H.; WIECHMANN, M.; RODY, J.; RYTZ, G.; SLONGO, M.; BIRBAUM, J.-L.; J.
A phenyl‐bipyrimidine‐phenyl‐π‐interaction together with a trapping of BF4 counterions by solvent molecules form the basis for the intense solid‐state luminescence of the title complexes (X: BF4).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.